Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC and Ketamine Interaction in Healthy Humans
NCT04199468Phase 1Completed
- Sponsor
- Yale University
- Start
- Sep 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol and ketamine (4 arms), sponsored by Yale University. Primary endpoints: EEG Indices of Information Processing (Neural Oscillations), Neurochemical Measures: THC levels and 3 more. Started Sep 2019; status: completed.
02
Drugs
dronabinolketamine
Beyond the preview
Go deeper on NCT04199468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04199468.